Study reveals how a promising bacterial therapy reduces recurrent bacterial vaginosis
A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture yet of how a promising bacterial therapy works to prevent recurrent bacterial vaginosis (BV) and why it works better for some women than others. BV is the most common vaginal condition worldwide, affecting more than 25% … Read more